Assessing the Impact of Vaccination and Medical Resource Allocation on Infectious Disease Outbreak Management: a Case Study of COVID-19 in Taiyuan City

Overview

Journal Front Public Health

Specialty Public Health

Date 2024 Aug 26

PMID 39185114

Authors

Jiaming Guo

Yuxin Luo

Yifei Ma

Shujun Xu

Jiantao Li

Tong Wang

Lijian Lei

Lu He

Hongmei Yu

Jun Xie

Affiliations

Soon will be listed here.

Abstract

Introduction: Amidst an emerging infectious disease outbreak, the rational allocation of vaccines and medical resources is crucial for controlling the epidemic's progression.

Method: Analysing COVID-19 data in Taiyuan City from December 2022 to January 2023, this study constructed a dynamics model to assess the impact of COVID-19 vaccination and resource allocation on epidemic trends.

Results: Vaccination significantly reduces infection rates, hospitalisations, and severe cases, while also curtailing strain on medical resources by reducing congestion periods. An early and sufficient reserve of medical resources can delay the onset of medical congestion, and with increased maximum capacity of medical resources, the congestion's end can be accelerated. Stronger resource allocation capabilities lead to earlier congestion resolution within a fixed total resource pool.

Discussion: Integrating vaccination and medical resource allocation can effectively reduce medical congestion duration and alleviate the epidemic's strain on medical resource capacity (CCMR).

References

Oh J, Apio C, Park T . Mathematical modeling of the impact of Omicron variant on the COVID-19 situation in South Korea. Genomics Inform. 2022; 20(2):e22. PMC: 9299565. DOI: 10.5808/gi.22025. View

Ali A, Ullah S, Khan M . The impact of vaccination on the modeling of COVID-19 dynamics: a fractional order model. Nonlinear Dyn. 2022; 110(4):3921-3940. PMC: 9420075. DOI: 10.1007/s11071-022-07798-5. View

Wang X, Li Q, Sun X, He S, Xia F, Song P . Effects of medical resource capacities and intensities of public mitigation measures on outcomes of COVID-19 outbreaks. BMC Public Health. 2021; 21(1):605. PMC: 8006107. DOI: 10.1186/s12889-021-10657-4. View

Dananche C, Elias C, Henaff L, Amour S, Kuczewski E, Gustin M . Baseline clinical features of COVID-19 patients, delay of hospital admission and clinical outcome: A complex relationship. PLoS One. 2022; 17(1):e0261428. PMC: 8741026. DOI: 10.1371/journal.pone.0261428. View

Ma Y, Xu S, Luo Y, Li J, Lei L, He L . Model-based analysis of the incidence trends and transmission dynamics of COVID-19 associated with the Omicron variant in representative cities in China. BMC Public Health. 2023; 23(1):2400. PMC: 10693062. DOI: 10.1186/s12889-023-17327-7. View

Wang J, Zheng X, Chen J . Clinical progression and outcomes of 260 patients with severe COVID-19: an observational study. Sci Rep. 2021; 11(1):3166. PMC: 7862220. DOI: 10.1038/s41598-021-82943-5. View

Marino S, Hogue I, Ray C, Kirschner D . A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol. 2008; 254(1):178-96. PMC: 2570191. DOI: 10.1016/j.jtbi.2008.04.011. View

Stoss C, Steffani M, Kohlhaw K, Rudroff C, Staib L, Hartmann D . The COVID-19 pandemic: impact on surgical departments of non-university hospitals. BMC Surg. 2020; 20(1):313. PMC: 7711305. DOI: 10.1186/s12893-020-00970-x. View

Andronico A, Menudier L, Salje H, Vincent M, Paireau J, De Valk H . Comparing the Performance of Three Models Incorporating Weather Data to Forecast Dengue Epidemics in Reunion Island, 2018-2019. J Infect Dis. 2023; 229(1):10-18. PMC: 10786251. DOI: 10.1093/infdis/jiad468. View

10.

Wiemken T, Khan F, Puzniak L, Yang W, Simmering J, Polgreen P . Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe. Sci Rep. 2023; 13(1):3886. PMC: 9994397. DOI: 10.1038/s41598-023-31057-1. View

11.

Ma X, Luo X, Li L, Li Y, Sun G . The influence of mask use on the spread of COVID-19 during pandemic in New York City. Results Phys. 2022; 34:105224. PMC: 8782758. DOI: 10.1016/j.rinp.2022.105224. View

12.

Cheyne A, Muchamore I, Tulunay H, Rojek A, Peto L, Horby P . Community Involvement in an Outbreak-One Year on for Mpox. Clin Infect Dis. 2023; 79(1):278-280. PMC: 11259207. DOI: 10.1093/cid/ciad745. View

13.

Lafond K, Porter R, Whaley M, Suizan Z, Ran Z, Aleem M . Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis. PLoS Med. 2021; 18(3):e1003550. PMC: 7959367. DOI: 10.1371/journal.pmed.1003550. View

14.

Ma Y, Xu S, An Q, Qin M, Li S, Lu K . Coronavirus disease 2019 epidemic prediction in Shanghai under the "dynamic zero-COVID policy" using time-dependent SEAIQR model. J Biosaf Biosecur. 2022; 4(2):105-113. PMC: 9212988. DOI: 10.1016/j.jobb.2022.06.002. View

15.

Zhao S, Chen H . Modeling the epidemic dynamics and control of COVID-19 outbreak in China. Quant Biol. 2020; 8(1):11-19. PMC: 7095099. DOI: 10.1007/s40484-020-0199-0. View

16.

Lipsitch M, Dean N . Understanding COVID-19 vaccine efficacy. Science. 2020; 370(6518):763-765. DOI: 10.1126/science.abe5938. View

17.

Peeri N, Shrestha N, Rahman M, Zaki R, Tan Z, Bibi S . The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?. Int J Epidemiol. 2020; 49(3):717-726. PMC: 7197734. DOI: 10.1093/ije/dyaa033. View

18.

Bhaskaran K, Rentsch C, Hickman G, Hulme W, Schultze A, Curtis H . Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform. PLoS Med. 2022; 19(1):e1003871. PMC: 8789178. DOI: 10.1371/journal.pmed.1003871. View

19.

Thomas S, Moreira Jr E, Kitchin N, Absalon J, Gurtman A, Lockhart S . Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. N Engl J Med. 2021; 385(19):1761-1773. PMC: 8461570. DOI: 10.1056/NEJMoa2110345. View

20.

Wang J, Chan Y, Niu R, Wong E, van Wyk M . Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants. Viruses. 2022; 14(7). PMC: 9319847. DOI: 10.3390/v14071482. View